Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
This study is currently recruiting participants.
Study NCT00629343   Information provided by Columbia University
First Received: February 26, 2008   Last Updated: October 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Soft Tissue Sarcoma
Mesothelioma
Additional conditions recognized in this trial
Sarcoma
More general conditions related to this trial
Adenoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Neoplasms, Glandular and Epithelial
Neoplasms, Mesothelial
Additional drug interventions recognized in this trial
Azacitidine
Temozolomide
More general drug interventions related to this trial
Alkylating Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Columbia University
Schering-Plough
Celgene Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services